AVEO Oncology signs development and option agreement with HiberCell

Tabelecleucel's BLA transferred from Atara Biotherapeutics to Pierre Fabre Laboratories

UCB's KYGEVVI receives FDA approval for TK2d treatment

Camurus launches Oczyesa in Germany for patients with acromegaly

Servier's VORANIGO (vorasidenib) receives Prix Galien USA Award

Bavarian Nordic secures new EU contract for up to 8 million smallpox and mpox vaccine doses

GenSight Biologics secures FDA authorisation for expanded access to GS010/LUMEVOQ in the US

Ascletis Pharma Inc selects ASC36 as clinical development candidate

Zoetis announces EU approval for Portela to relieve osteoarthritis pain in cats

European Commission approves Merck's KEYTRUDA (pembrolizumab) for resectable head and neck cancer expressing PD-L1

Samsung Bioepis to assume European commercialisation of BYOOVIZ (ranibizumab) from January 2026

Thermo Fisher Scientific to acquire Clario Holdings, expanding clinical data capabilities

FDA grants Augurex Life Sciences breakthrough designation for SPINEstat diagnostic test in axial spondyloarthritis

Shanton Pharma completes SAP-001 End-of-Phase 2 meeting with US FDA

Eli Lilly's single-injection, once-monthly maintenance Omvoh regimen receives US FDA approval